Home » Diseases » Disseminated Intravascular Coagulation: Disease Bioinformatics
Submit your image related to Diseases to be featured!
Submit an Image

Get Social

Submit your Twitter account related to Disseminated Intravascular Coagulation to be featured!
Submit an Account

Blogs

 Submit your blog on Disseminated Intravascular Coagulation to be featured!
Submit a Blog

Events

 Submit your event on Disseminated Intravascular Coagulation to be featured!
Submit an Event

Videos

Submit your video on Disseminated Intravascular Coagulation to be featured!
Submit a Video

Charities

Submit your charity on Disseminated Intravascular Coagulation to be featured!
Submit a Charity

Disseminated Intravascular Coagulation: Disease Bioinformatics

Research of Disseminated Intravascular Coagulation has been linked to Blood Coagulation Disorders, Hemorrhage, Systemic Infection, Thrombosis, Neoplasms. The study of Disseminated Intravascular Coagulation has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Disseminated Intravascular Coagulation include Coagulation, Fibrinolysis, Pathogenesis, Blood Coagulation, Hemostasis. These pathways complement our catalog of research reagents for the study of Disseminated Intravascular Coagulation including antibodies and ELISA kits against SLC25A10, F2, SERPINC1, PRH2, PLG.

Disseminated Intravascular Coagulation Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Disseminated Intravascular Coagulation below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 2503 products for the study of Disseminated Intravascular Coagulation that can be applied to Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.

Coagulation Factor II/Thrombin Antibody
NBP1-58268
Western Blot: Coagulation Factor II/Thrombin Antibody [NBP1-58268] - 721_B tissue lysate at a concentration of 1ug/ml.Immunohistochemistry: Coagulation Factor II/Thrombin Antibody [NBP1-58268] - Analysis of human liver after heat-induced Antigen retrieval. Antibody concentration 5 ug/ml.

Rabbit Polyclonal
Species Human, Mouse
Applications WB, IHC, IHC-P

     1 Review

3 Publications
TAT Antibody
NBP1-79286
Western Blot: TAT Antibody [NBP1-79286] - Rat Brain Lysate 1.0 ug/ml, gel concentration 12%

Rabbit Polyclonal
Species Rat
Applications WB

     1 Review

SLC25A10 Antibody
NBP1-85214
Western Blot: SLC25A10 Antibody [NBP1-85214] - Analysis in human cell line HepG2.Immunohistochemistry-Paraffin: SLC25A10 Antibody [NBP1-85214] - Staining of human kidney shows strong cytoplasmic positivity with granular pattern in cells in tubules and cells in glomeruli.

Rabbit Polyclonal
Species Human
Applications WB, IHC, IHC-P

Plasminogen Antibody
NB600-930
Western Blot: Plasminogen Antibody [NB600-930] - Lane 1: Plasminogen. Lane 2: None. Load: 50 ng per lane. Primary antibody: Plasminogen primary antibody at 1:1,000 overnight at 4C. Secondary antibody: Peroxidase goat secondary antibody at 1:40,000 for 60 min at RT. Blocking: incubated with blocking buffer for 30 min at RT. Predicted/Observed size: 91 kDa, 91 kDa for Plasminogen. Other band(s): None.Western Blot: Plasminogen Antibody [NB600-930] - Detection of Plasminogen under reducing (R) and non-reducing (NR) conditions. Reduced samples of purified target proteins contained 4% BME and were boiled for 5 minutes. Samples of 1ug of protein per lane were run by SDS-PAGE. Protein was transferred to nitrocellulose and probed with 1:3000 dilution of primary antibody. Detection shown was using Dylight 649 conjugated Donkey anti goat 1 hr RT.

Goat Polyclonal
Species Human, Rat
Applications WB, ELISA

     2 Reviews

6 Publications
Albumin Antibody (188835) [Unconjugated] - Serum
MAB1455
Western blot shows lysate of human liver tissue. PVDF membrane was probed with 1 µg/mL of Mouse Anti-Human Serum Albumin Monoclonal Antibody (Catalog # MAB1455) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # <a class=Albumin was detected in immersion fixed BG01V human embryonic stem cells differentiated to hepatocytes using Mouse Anti-Human Serum Albumin Monoclonal Antibody (Catalog # MAB1455) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # <a class=

Mouse Monoclonal
Species Human
Applications WB, Simple Western, IHC

     3 Reviews

31 Publications
Thrombomodulin/BDCA-3 [HRP]
DTHBD0
Thrombomodulin/BDCA-3 [HRP] Thrombomodulin/BDCA-3 [HRP]


Species Human
Applications ELISA

11 Publications
Coagulation Factor III/Tissue Factor [HRP]
DCF300
Coagulation Factor III/Tissue Factor [HRP] Coagulation Factor III/Tissue Factor [HRP]


Species Human
Applications ELISA

25 Publications
TFPI [HRP]
DTFP10
TFPI [HRP] TFPI [HRP]


Species Human
Applications ELISA

10 Publications
Holo-Transferrin [Unconjugated]
2914-HT


Species Human
Applications BA

37 Publications
Serpin E1/PAI-1 [HRP]
DSE100
Serpin E1/PAI-1 [HRP] Serpin E1/PAI-1 [HRP]


Species Human
Applications ELISA

43 Publications
IL-6 [HRP]
D6050
IL-6 [HRP] IL-6 [HRP]


Species Human
Applications ELISA

718 Publications
TNF-alpha [Unconjugated]
210-TA
Recombinant Human TNF-alpha (Catalog # 210-TA) has a molecular weight (MW) of 53.1 kDa as analyzed by SEC-MALS, suggesting that this protein is a homotrimer.  MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).Recombinant Human TNF-alpha (Catalog # 210‑TA) induces cytotoxicity in the L-929 mouse fibroblast cell line in the presence of the metabolic inhibitor actinomycin D. The ED<sub>50</sub> for this effect is 25‑100 pg/mL.


Species Human
Applications BA

     3 Reviews

746 Publications
Serpin C1/Antithrombin-III [Unconjugated]
1267-PI


Species Human
Applications InhibAct

6 Publications
t-Plasminogen Activator/tPA [HRP]
DTPA00
t-Plasminogen Activator/tPA [HRP] t-Plasminogen Activator/tPA [HRP]


Species Human
Applications ELISA

6 Publications
ATAT1 Antibody
NBP2-48990
Immunocytochemistry/Immunofluorescence: ATAT1 Antibody [NBP2-48990] - Staining of human cell line A-431 shows localization to cytosol. Antibody staining is shown in green.Immunohistochemistry-Paraffin: ATAT1 Antibody [NBP2-48990] - Staining of human testis show strong cytoplasmic positivity in cells in seminiferous ducts.

Rabbit Polyclonal
Species Human
Applications ICC/IF, IHC, IHC-P

Serpin F2/alpha 2-Antiplasmin Antibody
NB100-96916
Western Blot: Serpin F2/alpha 2-Antiplasmin Antibody [NB100-96916] - Staining of HepG2 cell lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence. Approx 70 kDa band observed in lysates of cell line HepG2 (calculated MW of 54.6 kDa according to NP_000925.2).Immunocytochemistry/Immunofluorescence: Serpin F2/alpha 2-Antiplasmin Antibody [NB100-96916] - Immunofluorescence analysis of paraformaldehyde fixed A431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).

Goat Polyclonal
Species Human
Applications WB, Flow, ICC/IF

3 Publications
Recombinant Human PRH2 GST (N-Term) Protein
H00005555-P01
SDS-Page: Recombinant Human PRH2 Protein [H00005555-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.


Species Human
Applications WB, ELISA, PA


Related Genes

Disseminated Intravascular Coagulation has been researched against:

Related Pathways

Disseminated Intravascular Coagulation has been linked to:

Related Diseases

Disseminated Intravascular Coagulation has been studied in relation to diseases such as:

Related PTMs

Disseminated Intravascular Coagulation has been studied in relation to posttranslational modifications (PTMs) including:

Alternate Names

Disseminated Intravascular Coagulation is also known as disseminated intravascular coagulation, disseminated intravascular coagulation (disorder), dissemin. intravascular coag., defibrination syndrome, diffuse, dic.